Braskem (BAK) Invested Capital (2009 - 2025)

Braskem (BAK) has reported Invested Capital for 17 consecutive years, with $9.6 billion the latest figure, recorded in Q4 2025.

• Quarterly Invested Capital rose 4.94% year-over-year to $9.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $23.6 billion (up 16.98% YoY) and the FY2025 annual result came in at $9.6 billion, up 4.94% from the prior year.
• Invested Capital rose to $9.6 billion in Q4 2025 per BAK's latest filing, from $2.3 billion in the prior quarter.
• Over the last five years, Invested Capital for BAK reached as high as $9.6 billion in Q4 2025 and fell as low as $2.3 billion in Q1 2025.
• A 5-year average of $6.5 billion and a median of $6.6 billion in 2021 frame the typical range for Invested Capital.
• The largest YoY upside for Invested Capital was 8781.26% in 2021 against a maximum downside of 19.06% in 2021.
• Year by year, Invested Capital stood at $6.3 billion in 2021, then advanced by 8.51% to $6.8 billion in 2022, then rose by 25.66% to $8.5 billion in 2023, then grew by 7.36% to $9.2 billion in 2024, then rose by 4.94% to $9.6 billion in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $9.6 billion, $2.3 billion, and $9.2 billion for Q4 2025, Q1 2025, and Q4 2024 respectively.